Open AccessP1111: COMPARATIVE EFFICACY AND SAFETY OF TISAGENLECLEUCEL AND AXICABTAGENE CILOLEUCEL IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA
Author(s) -
Dickinson M.,
MartinezLopez J.,
Jousseaume E.,
Anjos C.,
Yang H.,
Chai X.,
Wang T.,
Ramos R.,
LobettiBodoni C.,
Schuster S.,
Fowler N.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000847312.43465.58
Subject(s) - medicine , oncology , regimen , rituximab , follicular lymphoma , tocilizumab , cytokine release syndrome , surgery , lymphoma , chimeric antigen receptor , immunotherapy , cancer , disease